MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ('MediPharm,' the 'Company,' 'we' or 'us'), a pharmaceutical company specialized in precision-based cannabinoids, today reminded its shareholders that the deadline is approaching to cast your vote for the upcoming Annual and Special Meeting of Shareholders on June 16, 2025 (the 'Meeting'). All votes must be received no later than 3:00 p.m. (Eastern time) on Friday, June 13, 2025.
We encourage shareholders to please vote using ONLY the GREEN proxy or GREEN voting instruction card and to support each of the director nominees recommended by MediPharm's Board of Directors (the 'Board') and the other matters being considered at the Meeting. To ensure your proxy is counted at the Meeting, please submit it well in advance of the June 13 proxy cut-off.
Please remember that your vote is important, regardless of the number of shares you own.
MediPharm's Strategy Is Working
MediPharm has undergone a successful transformation over the past three years, led by David Pidduck who joined as CEO in April 2022. Faced with negative gross margins and an operating loss of $48.9 million in 2021, the Company implemented a plan to refocus operations, prioritizing the most strategic business lines, divesting of non-core assets and reducing operating costs. The acquisition of VIVO Cannabis Inc. in April 2023 provided a foundation to accelerate international growth and realize synergies from combining the two companies. We described our strategic turnaround in a Chair's Letter to Shareholders dated May 11, 2025.
In Q1 2025, we continued our track record of year-over-year revenue growth, led by an 87% revenue increase in the international medical market which now represents more than half our revenue. We achieved positive Adjusted EBITDA1 for the first time in more than five years and our gross profit margin of 38.7% was the highest in more than five years. Operating loss narrowed to less than $0.5 million, an improvement of more than $3 million from Q1 2024. A strong cash position with virtually no debt enabled us to invest in inventory to pursue near-term growth opportunities.
With diversification in our product mix and sales channels, a strong reputation as a GMP-certified producer and expanding international partnerships, MediPharm has established a solid foundation for further growth. We are confident the strategy and team currently in place is the best way to create sustainable value.
The Dissident Group has NOT Made a Case for Change
Apollo Technology Capital Corp. ('Apollo'), led by Chairman and CEO Regan McGee, and former MediPharm CEO and director Patrick McCutcheon (collectively, the 'Concerned Stakeholder'), have filed an amended and restated dissident proxy circular dated May 15, 2025, as updated by an addendum dated June 4, 2025, nominating six alternative directors (the 'Dissident Nominees') for the Board.
In recent weeks we have described numerous deficiencies in Apollo's plan and the track record of Mr. McGee and the other Dissident Nominees. With the addition of Pat McCutcheon to the dissident team, a number of new concerns now emerge. Important points for shareholders to remember include the following.
Apollo's strategic plan for MediPharm appears to have been hastily constructed and lacking in substance, while presenting current MediPharm strategies as their own. Apollo has shown inconsistencies regarding support for or aversion to M&A activities. We provided a detailed analysis of Apollo's inadequate plan in our Board Letter to Shareholders issued May 29, 2025.
Apollo's disclosure has been characterized by numerous misrepresentations and outright fabrications. We highlighted a small sample of the false statements they have made in an 'Apollo Myths vs. Facts' document on our AGM website.
Independent proxy voting and corporate governance advisory firm ISS met with Apollo, considered its arguments and its plans for the Company and concluded that Apollo did not make a compelling case for change. Please see our news release issued June 2, 2025 for more details.
The Dissident Nominees have potential conflicts of interest and a web of interlocking relationships that would impair their independence as Board members. We described these problems in our May 15, 2025 news release.
Patrick McCutcheon's Tenure at MediPharm
Mr. McCutcheon, who is now formally acknowledged as a member of the Concerned Stakeholder dissident group, served as CEO of MediPharm until December 10, 2020, Chairman of the Board until August 16, 2021, and as a director until December 7, 2021. While Apollo has been critical of the current leadership team's performance on such measures as share price, revenue growth, gross profit, cash usage and operating loss, we note the following about Mr. McCutcheon's track record with the Company.
One of Apollo's primary arguments has been that the current MediPharm team has been responsible for the decrease in the Company's share price since its peak on May 14, 2019. Of the total decrease in share price since May 14, 2019, more than 97% occurred while Mr. McCutcheon served as Chairman, CEO or director. Less than 1% of the total decrease has occurred since David Pidduck joined as CEO on April 20, 2022.
In 2020, Mr. McCutcheon's final year as CEO, the Company's revenue decreased by 72% year-over-year with gross profit of negative $44.0 million, cash from operations of negative $37.8 million, and operating income of negative $72.6 million.
We note Apollo's reference to the decrease in the Company's asset values over time. Some of this asset decrease was in fact due to the write-offs required as a result of Mr. McCutcheon's excessive multi-year capital expenditure program including the procurement of millions of dollars of equipment, much of which was not needed and was never used.
The Board urges shareholders to send Mr. McGee and Mr. McCutcheon a strong message that you want to stop their expensive and aggressive attacks against your Company.
Vote for the Highly Qualified MediPharm Nominees
MediPharm urges shareholders to vote only using the GREEN proxy or GREEN voting instruction form in support of all of the Company's nominees and resolutions.
To ensure your vote is counted, shareholders are encouraged to proactively contact their broker to obtain their 16-digit control number associated with the GREEN management proxy. Once received, you can cast your vote by visiting .
You may receive materials or outreach from the dissident — please disregard any such communications and vote only using the GREEN proxy in support of the Company's nominees.
About MediPharm Labs
Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities for delivery of pure, trusted and precision-dosed cannabis products for its customers. MediPharm Labs develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets.
In 2021, MediPharm Labs received a Pharmaceutical Drug Establishment License from Health Canada, becoming the only company in North America to hold a commercial-scale domestic Good Manufacturing Practices License for the extraction of multiple natural cannabinoids. This GMP license was the first step in the Company's current foreign drug manufacturing site registration with the US FDA.
In 2023, MediPharm acquired VIVO Cannabis Inc., which expanded MediPharm's reach to medical patients in Canada via Canna Farms medical ecommerce platform, and in Australia and Germany through Beacon Medical Australia PTY Ltd. and Beacon Medical Germany GMBH. This acquisition also included Harvest Medical Clinics in Canada which provides medical cannabis patients with Physician consultations for medical cannabis education and prescriptions.
The Company carries out its operations in compliance with all applicable laws in the countries in which it operates.
Shareholder Voting Assistance:
If you have any questions or require any assistance in executing your GREEN proxy or voting instruction form, please call Sodali & Co at:
North American Toll-Free Number: 1.888.777.2059Outside North America, Banks, Brokers and Collect Calls: 1.289.695.3075Email: assistance@investor.sodali.comNorth American Toll-Free Facsimile: 1.877.218.5372
For up-to-date information and assistance in voting please visit: www.medipharmlabsagm.com
Investor Contact:
MediPharm Labs Investor RelationsTelephone: +1 416.913.7425Email: investors@medipharmlabs.com
Media Contact:
John VincicOakstrom Advisors+1 (647) 402-6375john@oakstrom.com
Cautionary Note Regarding Forward-Looking Information:
This news release contains 'forward-looking information' and 'forward-looking statements' (collectively, 'forward-looking statements') within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as 'expects', or 'does not expect', 'is expected', 'anticipates' or 'does not anticipate', 'plans', 'budget', 'scheduled', 'forecasts', 'estimates', 'believes' or 'intends' or variations of such words and phrases or stating that certain actions, events or results 'may' or 'could', 'would', 'might' or 'will' be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things: timing of the Annual and Special Meeting, the ability of the Company to pursue near-term growth opportunities, future growth opportunities available to the Company, sustainable value creation at MediPharm, any impacts to MediPharm shareholders of the actions relating to the Dissident Nominees described herein, and any outcomes resulting from the circumstances and information cited herein. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the inability of MediPharm Labs to obtain adequate financing; the delay or failure to receive regulatory approvals; and other factors discussed in MediPharm Labs' continuous disclosure filings, available on the SEDAR+ website at www.sedarplus.ca. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, MediPharm Labs assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.
___________________________________
1 Represents a non-GAAP financial measure, which is not a standardized financial measure under IFRS and which might not be comparable to similar financial measures disclosed by other issuers. MediPharm calculates Adjusted EBITDA as net income (loss) with interest, taxes, depreciation and amortization, non-cash adjustments and other unusual or non-recurring items added back. Refer to the sections entitled 'Use of Non-IFRS Financial Measures' and 'Reconciliation of Non-IFRS Measures' in MediPharm's management's discussion and analysis for the three months ended March 31, 2025, which is incorporated by reference herein and which can be located on MediPharm's profile on SEDAR+ at www.sedarplus.ca.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
OPEC+ agrees to boost oil production by 547,000 barrels per day from September
Eight OPEC+ countries meeting on Sunday agreed on a bump in oil production for September by 547,000 barrels per day. View on euronews Related videos How much do you need in an ISA to aim for a £1,000 monthly passive income? £50k in savings? Here's how to unlock up to £4.5k in passive income overnight Down 55% in 5 years, but this FTSE stock offers a 9.5% dividend yield for income investors! Meet the 75p dividend stock with a higher yield than Legal & General shares Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
iTagPro: How iTag Pro Is Reinventing the Bluetooth GPS Tracker Market - Read iTagPro GPS Tracker Report
Tracker Report Discover how iTagPro is redefining Bluetooth GPS Trackers in 2025. Read real tech insights, and GPS Tracker performance facts before you buy. iTagPro New York City, NY, Aug. 03, 2025 (GLOBE NEWSWIRE) -- As Bluetooth-enabled location technology becomes essential for modern lifestyles, the iTagPro GPS Tracker is emerging as a market disruptor. Designed to help users locate keys, wallets, luggage, and even pets, iTagPro combines precision GPS tracking with sleek Bluetooth integration. iTagPro isn't just another Bluetooth GPS Tracker—it's shaping the future of personal item security in Is iTagPro? Product Overview & Claims As personal tracking devices continue gaining popularity, iTagPro is positioning itself as a next-generation Bluetooth GPS Tracker tailored for everyday use. Marketed as a compact, smart solution for preventing lost items, iTagPro claims to combine GPS-level precision with Bluetooth convenience—bringing real-time location awareness to your fingertips. On the official iTagPro website, the device is described as a 'reliable GPS Tracker' that offers real-time tracking, geofencing, anti-theft alerts, and Bluetooth + GPS integration. These phrases suggest a robust tracking solution that can monitor keys, wallets, luggage, or pets across wide distances. The device is also advertised with claims of long battery life, ease of use, and compatibility with both iOS and Android smartphones. iTagPro's promotional content emphasizes peace of mind for users who are constantly on the move. Phrases like 'never lose what matters' and 'track in real time' reinforce the perception that the device functions as a full-fledged GPS tracker. The product is also highlighted for its sleek design and app-based controls, which appeal to tech-savvy shoppers looking for a practical, plug-and-play solution. However, while the marketing positions iTagPro as a GPS-enabled tool, deeper technical reviews suggest that it primarily operates via Bluetooth Low Energy (BLE), relying on a user's phone to log location history. Once the Bluetooth connection is lost, the tracking stops—indicating that GPS functionality is not built into the device itself. In short, iTagPro is promoted as a GPS Tracker but functions primarily as a Bluetooth locator. For consumers, this distinction is essential when evaluating whether the product truly meets their tracking needs—or simply offers short-range item-finding convenience dressed in GPS language. View official iTag Pro website for latest best pricing and promotions What Makes iTagPro Different From Other Bluetooth GPS Trackers? As Bluetooth GPS Tracker solutions gain traction in households across the U.S., the iTagPro is carving out its own lane in the market. Promoted as a sleek, compact GPS Tracker, iTagPro distinguishes itself through an app-based interface, item finder alerts, and sleek product design. Unlike conventional Bluetooth trackers such as Tile or AirTag, iTag Pro markets itself with claims of 'GPS-level precision' and wider utility—particularly for those who want more than simple proximity alerts. However, while the branding emphasizes GPS capabilities, it's important to note that the device primarily operates via Bluetooth, not satellite-based GPS tracking. iTagPro's standout feature lies in its visual appeal and accessibility—it doesn't require brand-specific ecosystems like Apple's Find My network, which means it's compatible with both Android and iOS devices. For consumers seeking a universal Bluetooth GPS Tracker, this is a major plus. What also sets iTagPro apart is its aggressive positioning through exclusive 'limited-time' discounts, bundling offers, and promises of extended range—all designed to appeal to both tech novices and frequent travelers. This marketing strategy has certainly helped the product trend in consumer electronics categories. However, reviewers and tech experts have urged shoppers to examine the technical specifications closely. Without real GPS functionality, iTagPro may not meet expectations for long-distance item tracking. In short, iTagPro differentiates itself more in branding than core performance. Its simplicity and compatibility may attract casual users—but for those needing true GPS capabilities, comparisons with higher-end trackers are strongly Setup, Easy Tracking—Visit Official iTagPro Website For More Information Real-World Applications: How iTagPro Helps You Track Everyday Items From misplacing keys to locating your bag at the airport, iTagPro is pitched as an all-purpose solution for keeping tabs on daily essentials. In an increasingly mobile world, Bluetooth GPS Trackers like iTagPro promise users a sense of digital reassurance. But how does it actually perform when put to everyday use? Designed to attach easily to keyrings, wallets, backpacks, or pet collars, iTagPro connects via Bluetooth to its companion mobile app. Once paired, users can use their smartphone to trigger an alert sound from the device or check its 'last known location' on a digital map. This helps recover misplaced items within a Bluetooth range of approximately 30 feet indoors and 100 feet outdoors—assuming no major signal interference. For close-range tracking—like locating your wallet inside the house or a bag left behind in the office—iTagPro performs similarly to competitors like Tile. The app interface is relatively simple, allowing users to see multiple tagged items and monitor signal strength for each one. However, iTagPro does not use cellular towers or satellite GPS for tracking. This makes it less effective for real-time tracking over long distances—such as if you leave your bag in a taxi or your dog runs several blocks away. In those scenarios, iTagPro won't track location in real time once the Bluetooth connection is lost. While the product does serve practical functions within a limited range, it should be seen as a Bluetooth tracker—not a GPS tracker in the traditional sense. Consumers using iTag Pro for casual, short-range recovery of everyday items will find it helpful—but those expecting long-distance GPS tracking will be left disappointed. Never Lose a Thing Again with iTag Pro - Visit official iTagPro website Inside the Tech: How iTagPro Uses Bluetooth & GPS for Seamless Tracking iTagPro is often promoted as a Bluetooth GPS Tracker, but what's under the hood tells a more nuanced story. While the name implies satellite-based navigation, iTagPro operates almost entirely on Bluetooth Low Energy (BLE)—a proximity-based technology, not true GPS. The device pairs with a smartphone app via Bluetooth, using your phone's GPS and data connection—not the tracker's—for location pinpointing. When an item goes missing, the iTagPro app simply shows the last place where your phone was connected to the device. It does not provide continuous location tracking or communicate with satellites independently. In short, there's no onboard GPS chip in the tracker itself. This is a major difference compared to true GPS Trackers like Invoxia or Jiobit, which have built-in GPS modules and SIM cards for cellular connectivity. Bluetooth has limitations. The connection typically holds within 30–100 feet, depending on obstructions and interference. If the tagged item leaves that range, tracking stops until the device is found again. This is suitable for home or office environments but not effective for monitoring children, vehicles, or pets across city blocks. The claim of GPS-level performance is largely a marketing term—the iTag Pro piggybacks on your phone's GPS when within range but offers no real tracking once disconnected. For users who want basic tracking within close proximity, iTagPro works fine. But for seamless GPS tracking, it doesn't deliver on the expectations its branding sets. Knowing this helps consumers distinguish between Bluetooth-based convenience and actual satellite-powered GPS tracking solutions. Never Lose Keys, Bags, or Pets Again—iTagPro Now Available Online How Long Does iTagPro Last? Battery Life and Durability Breakdown For any Bluetooth GPS Tracker to be considered reliable, battery life and hardware durability are critical. iTagPro advertises 'long-lasting performance,' but how well does the device hold up in real-world conditions?According to its official product description, iTagPro is powered by a CR2032 coin cell battery, a standard component in many Bluetooth tracking devices. The brand claims a battery life of up to 6 months, depending on usage and Bluetooth activity. However, this figure is based on ideal conditions—real-world use may shorten lifespan significantly if you're using frequent ring alerts, multiple devices, or constant app battery is replaceable, which is a plus. Users can access the battery by gently prying open the device's casing. Still, there's a catch: the iTagPro casing is not designed for routine opening. It lacks a dedicated battery compartment or simple twist-off cover, so the removal process can feel awkward and risks damaging the plastic terms of durability, iTagPro is lightweight and compact, but not particularly rugged. There's no mention of IP67 or water-resistance certification, making it unsuitable for environments where moisture or drops are common. Users report that while the tracker holds up well on keychains or bags, it's not ideal for pet collars or outdoor gear where wear and tear are iTagPro meets basic expectations for battery life and daily handling, it isn't built for heavy-duty use or rough conditions. The lack of a user-friendly battery replacement method and limited waterproofing may be concerns for long-term line: iTagPro offers decent short-term performance, but buyers looking for year-round resilience and field-tested durability may want to explore more robust Bluetooth or GPS tracker alternatives. Where to Buy iTagPro and How to Get Started iTagPro is currently available for purchase exclusively through its official website, where customers can choose from single or multi-pack offers with limited-time discounts. Each iTagPro unit comes with a small setup guide, and buyers are prompted to download the mobile app from the App Store or Google Play. Pairing the device with your phone is relatively simple: hold the tracker near your phone, launch the app, and follow the on-screen instructions to connect via Bluetooth. The site claims a 'risk-free' guarantee, but customer reviews suggest that refund requests are often delayed or denied. Therefore, if you're purchasing iTagPro, it's advisable to read the refund policy in full and consider using a payment method with buyer protection (such as PayPal or a credit card). As for ongoing costs, there are no monthly fees—a benefit over traditional GPS Trackers that require cellular subscriptions. However, this also underscores that the product is Bluetooth-only and not a true GPS device. To get started, simply visit the official iTagPro website, select your preferred bundle, and complete checkout. Be aware of potential upsells during the checkout process, such as extended warranties or VIP support services, which add to the cost. iTag Pro Setup Experience: How Easy Is It to Connect and Use? For a Bluetooth GPS Tracker to be effective, it must be easy to set up and operate. iTagPro advertises a seamless onboarding experience—and while the process is generally straightforward, user reviews reveal mixed results in real-world purchasing iTagPro from the official website, users are instructed to download the iTagPro app, available on both Android and iOS platforms. The initial steps are simple: enable Bluetooth, open the app, and press the device's power button until it's detected. Once connected, the tracker appears on your dashboard, where you can assign a label (like 'keys' or 'wallet') and begin app's interface is minimalist, with basic functions such as 'ring device,' 'last seen location,' and 'disconnect alert.' For users with multiple iTagPro units, the app allows multi-device tracking, which is ideal for households managing several connection reliability varies. Some users report the pairing process fails unless the tracker is held extremely close to the phone. Others note that the device frequently disconnects—even when still within advertised Bluetooth range. Reconnecting requires closing and reopening the app or restarting Bluetooth the compatibility across iPhone and Android is a strength, the app has received criticism for occasional glitches, slow loading times, and minimal location refresh accuracy. It's also important to understand that location updates depend on your phone's GPS, not the tracker line: iTagPro setup is simple in theory, but may demand patience in practice. Tech-savvy users will find it manageable, but casual buyers expecting instant, long-range GPS tracking may be frustrated by the limited scope of what a Bluetooth-based device can Assessment: Should You Believe the Hype? The iTagPro is promoted as a must-have Bluetooth GPS Tracker, but real-world testing reveals a different story. While it does offer functionality as a Bluetooth-enabled item locator, its claims of GPS-level tracking and extended range are misleading. iTagPro's appeal lies in its simplicity and price-point marketing—but the technology under the hood doesn't match the expectations set by its branding. There is no built-in GPS, no SIM card, and no satellite or cellular tracking. Once the Bluetooth connection is lost, the device offers no way to locate your item unless you return within range. From a consumer protection standpoint, this presents an issue. Many buyers believe they are purchasing a GPS Tracker capable of real-time monitoring across long distances, only to realize the device cannot perform those tasks. Refunds and customer service responses have also been inconsistent, according to independent review sites and user feedback. So, should you believe the hype? That depends on your expectations. If you're looking for a basic Bluetooth tracker to help you locate keys or bags in your home or office, iTag Pro performs adequately. But if you're seeking a GPS Tracker that can track stolen luggage, vehicles, or pets across wide areas, this product falls short. In the end, iTagPro delivers basic tracking but overpromises on its capabilities. It's crucial for journalists, reviewers, and consumers alike to understand the distinction between Bluetooth trackers and actual GPS Trackers—especially when evaluating product claims that blur that line. For more information, educational content, and direct purchasing, visit the official iTagPro website. Contact & Company Info UAB Commerce Core, Savanorių pr. 363, Kaunas, LithuaniaEmail: support@ Order Phone Support: +1 (380) 268-0220 Website: and Disclosures The information presented in this article is for educational and informational purposes only. Every effort has been made to ensure the accuracy of the content at the time of publication; however, errors, omissions, or typographical issues may occur. Readers are encouraged to verify product details, features, and promotional pricing by visiting the official website of the product mentioned. All claims regarding the iTagPro, including those related to durability, health benefits, and maintenance, are based on publicly available information, user testimonials, or manufacturer-provided details. No medical advice is provided or implied. Always consult with a qualified professional before making decisions related to health, safety, or personal technology use. iTagPro is not a medical device and is not designed to prevent emergencies, replace emergency services, or guarantee safety in any circumstance. Use of the product is at the discretion and responsibility of the consumer. Attachment iTagPro CONTACT: Contact & Company Info UAB Commerce Core, Savanorių pr. 363, Kaunas, Lithuania Email: support@ Order Phone Support: +1 (380) 268-0220 Website:
Business Upturn
5 hours ago
- Business Upturn
AAPL LEGAL ALERT: Lose Money on Your Apple Inc. Investment? Contact BFA Law by August 19 Class Action Deadline (NASDAQ:AAPL)
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Apple Inc. (NASDAQ: AAPL) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Apple, you are encouraged to obtain additional information by visiting: Investors have until August 19, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Apple securities. The case is pending in the U.S. District Court for the Northern District of California and is captioned Tucker v. Apple Inc., et al. , No. 5:25-cv-05197. Why was Apple Sued for Securities Fraud? Apple is a multinational technology company that engages primarily in the businesses of smart-devices and artificial intelligence ('AI'). Apple's software includes a digital personal assistant called 'Siri,' which was first introduced in October 2011. The complaint alleges that Apple misrepresented Siri's advanced AI-based features as well as its ability to deliver them within the iPhone 16 product cycle. In truth, as alleged, Apple lacked a functional prototype of Siri's purported advanced AI-based features and misrepresented the time it would take to integrate such features into its devices. The Stock Declines as the Truth is Revealed On March 7, 2025, Apple announced it was indefinitely delaying several AI-based Siri features, citing development delays and pushing their release to sometime 'in the coming year.' On this news, the price of Apple stock declined $11.59 per share, or almost 5%, from $239.07 per share on March 7, 2025, to $227.48 per share on March 10, 2025, the following trading day. Then, on June 9, 2025, Apple hosted its Worldwide Developer Conference for 2025. Noticeably, Apple failed to announce any new updates regarding advanced Siri features. Analysts and media outlets described the WWDC as 'underwhelming' and 'disappointing,' with CNN stating that 'it's unlikely that any of the announcements made at Monday's event will change the perception that Apple is behind its competitors in AI.' On this news, the price of Apple stock declined $2.47 per share, or over 1%, from $203.92 on June 6, 2025, to $201.45 per share on June 9, 2025, the following trading day. Click here for more information: What Can You Do? If you invested in Apple you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Submit your information by visiting: Or contact:Ross Shikowitz [email protected] 212.789.3619
